|
Background
|
BIRC6 is a member of a family of proteins that inhibit apoptosis, likely through interference with activation of ICE-like proteases. BIRC6, which contains a single BIR domain and a ubiquitin-conjugating enzyme domain, is expressed in four of six brain cancers (gliomas), and one of five ovarian cancers in a variety of human cancer cell lines. Brain cancer cell lines that overexpress BIRC6 demonstrate multi-drug resistance BIRC6 may protect cancer cells from undergoing apoptosis and participate in tumorigenesis and drug resistance.
|
Background
References
|
- Chen, Z., et al., Biochem. Biophys. Res. Commun. 264(3):847-854 (1999).
|
Order Information
List Price (USA): $235.00/0.1mg
Related Products
Data Rewards Program
